O13: Oral infigratinib for children with achondroplasia: Month 18 results from the PROPEL 2 study

O13: Oral infigratinib for children with achondroplasia: Month 18 results from the PROPEL 2 study

Saved in:
Bibliographic Details
Main Authors: Ravi Savarirayan, Elena Muslimova, Josep Bergua, Paul Arundel, Jean Salles, Vrinda Saraff, Borja Delgado, Antonio Leiva-Gea, Helen McDevitt, Marc Nicolino, Massimiliano Rossi, Maria Salcedo, Valerie Cormier-Daire, Mars Skael, Peter Kannu, John Phillips, Howard Saal, Paul Harmatz, Toby Candler, Richard Weng, Yun Bai, Supriya Raj, Julie Hoover-Fong, Melita Irving, Daniela Rogoff
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Genetics in Medicine Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2949774425001281
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:2949-7744

Similar Items